2-Thiazolamine, 4-(trifluoromethyl)- → 6-{(E)-2-[2-(Cyclobutylmethoxy)-3-(difluoromethoxy)phenyl]vinyl}-N-[4-(trifluoro-methyl)-1,3-thiazol-2-yl]imidazo[2,1-b][1,3]thiazole-5-carboxamide

HRID 1882172Notes

Reaction equation

HRID 1882172 reaction equation
[CH:1]1([CH2:5][O:6][C:7]2[C:12]([O:13][CH:14]([F:16])[F:15])=[CH:11][CH:10]=[CH:9][C:8]=2/[CH:17]=[CH:18]/[C:19]2[N:20]=[C:21]3[N:25]([C:26]=2[C:27](O)=[O:28])[CH:24]=[CH:23][S:22]3)[CH2:4][CH2:3][CH2:2]1.[F:30][C:31]([F:39])([F:38])[C:32]1[N:33]=[C:34]([NH2:37])[S:35][CH:36]=1.CCN=C=NCCCN(C)C.Cl>CN(C1C=CN=CC=1)C.C1COCC1.CN(C=O)C>[CH:1]1([CH2:5][O:6][C:7]2[C:12]([O:13][CH:14]([F:16])[F:15])=[CH:11][CH:10]=[CH:9][C:8]=2/[CH:17]=[CH:18]/[C:19]2[N:20]=[C:21]3[N:25]([C:26]=2[C:27]([NH:37][C:34]2[S:35][CH:36]=[C:32]([C:31]([F:39])([F:38])[F:30])[N:33]=2)=[O:28])[CH:24]=[CH:23][S:22]3)[CH2:4][CH2:3][CH2:2]1

Participants

7

Reactant 3

HCID 12014172-Thiazolamine, 4-(trifluoromethyl)-HCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 593699316-{(E)-2-[2-(Cyclobutylmethoxy)-3-(difluoromethoxy)phenyl]vinyl}imidazo[2,1-b][1,3]thiazole-5-carboxylic acid

Product 1

HCID 468344136-{(E)-2-[2-(Cyclobutylmethoxy)-3-(difluoromethoxy)phenyl]vinyl}-N-[4-(trifluoro-methyl)-1,3-thiazol-2-yl]imidazo[2,1-b][1,3]thiazole-5-carboxamide

Reagents, catalysts & solvents 3

HCID 142844-(Dimethylamino)pyridineCatalystHCID 6228DimethylformamideSolventHCID 8028TetrahydrofuranSolvent

Procedure

The title compound was prepared according to the general procedure (Method B) by coupling Intermediate 10 (300 mg, 0.714 mmol) with 4-(trifluoromethyl)-1,3-thiazol-2-amine (128 mg, 0.785 mmol) in the presence of EDCI hydrochloride (273 mg, 1.428 mmol), DMAP (80 mg, 0.714 mmol) in a mixture of THF and DMF (1:1, 6 mL) to give 27 mg of the product as an off-white solid; 1H NMR (300 MHz, CDCl3) δ 1.80-1.90 (m, 4H), 1.98-2.08 (m, 2H), 2.66-2.76 (m, 1H), 3.89-3.95 (m, 2H), 7.15-7.25 (m, 3H), 7.40-7.47 (m, 1H), 7.52-7.67 (m, 2H), 7.78 (d, J=15.9 Hz, 1H), 8.00-8.10 (m, 2H), 13.03 (br s, 1H); APCI-MS (m/z) 571.18 (MH)+.

Sources & evidence

ORD record
ord-7c7af20ab935471eae6744d859b07f98
Source dataset
uspto-grants-2012_11
Patent number
US08318928B2

Reaction notes

Loading…